- This event has passed.
Life Sciences Innovation Evenings with Johnson & Johnson
May 19 @ 5:00 pm - 7:30 pm
If you’re developing or investing in transformational innovation in the areas of interest to Johnson & Johnson, then this exclusive networking event series is for you.
Hosted by J&J’s external scientific innovation group at the London Innovation Centre on 28 April, 19 May and 16 June, you may register to join one of these three dates while seats are available.
The evening will feature a brief introduction highlighting Johnson & Johnson’s key areas of scientific interest and collaboration models across the pharmaceuticals and medical technology sectors. After the introduction, attendees will have the chance to connect with fellow innovators and J&J representatives during a networking session.
Space is limited, so be sure to reserve a spot for the date you wish to attend. We look forward to fostering connections and inspiring conversations that drive innovation in our industry.
Who is this event series for?
These events are intended for emerging companies and early-stage innovators developing pharmaceutical assets, novel therapy or medical technology products in the areas of interest for J&J (click here for pharmaceuticals and MedTech). Innovators in the data sciences, digital health, drug discovery and development, or platform technology areas are also welcome. Stakeholders with a portfolio of start-ups, such as VCs, TTOs or incubators are encouraged to attend.
Suppliers, service providers or other professional services companies are out of scope and their registrations will not be accepted.
What is J&J’s external scientific innovation group?
Our goal is to help life science and health technology innovations thrive through collaboration and partnership with the global ecosystem, so that together we can change the trajectory of human health. The group works across the pharmaceutical and medical technology sectors to accelerate early-stage, transformational solutions by catalyzing the best ideas, wherever they are in the world. We do this by harnessing our deep scientific capabilities coupled with a wide range of tools, including customized deal structures, company creation, incubation and start-up services, capital investments and other innovative business models that aim to meet the diverse needs of entrepreneurs, scientists and emerging companies.